Presentation on theme: "Million Hearts® and Sodium: Best Practices and Opportunities"— Presentation transcript:
1 Million Hearts® and Sodium: Best Practices and Opportunities August 22, 20132:00pm - 3:00pmThe CDC Million Hearts® Collaboration encourages states to get involved with Million Hearts®. The CDC Million Hearts Collaboration created a State Engagement Guide to support states in their Million Hearts efforts. The Guide includes information on the initiative as well as ways to support Million Hearts®, lessons learned and key recommendations, workshop descriptions and examples, resources, and information on how the Collaboration organizations can assist you in working with Million Hearts®.
2 Welcome & OverviewJill Birnbaum, JD Vice President, State Advocacy & Public Health American Heart Association
3 Agenda Time Agenda Item / Topic Speaker / Facilitator 3:00 Welcome, OverviewJill Birnbaum, JD, Vice President, State Advocacy & Public Health, American Heart Association3:05AHA Sodium Conference HighlightsEmily Ann Miller, Emily Ann Miller, MPH, RD, National Program Lead, Sodium Reduction Initiative, American Heart Association3:20Sodium Intake in Populations: Assessment of Evidence, 2013 IOM ReportCheryl Anderson, Cheryl A. M. Anderson, PhD, MPH, MS, Associate Professor, Department of Family and Preventive Medicine, University of California San Diego School of Medicine3:35Future Direction of Procurement PolicyLaurie Whitsel, Ph.D., Director of Policy Research, American Heart Association3:45Million Hearts Support and EngagementJohn Clymer, Executive Director, National Forum for Heart Disease and Stroke Prevention3:55Q and AFacilitated by Jill Birnbaum, JD, Vice President, State Advocacy & Public Health, American Heart AssociationWelcome to the Million Hearts® and Sodium: Best Practices and Opportunities Webinar. This webinar is hosted by the American Heart Association and the National Forum for Heart Disease and Stroke Prevention. You will learn how your organization can address sodium reduction in the United States and work with Million Hearts®.Decreasing sodium intake of the population is one of the objectives under Goal 1: Prevent and control high blood pressure from the Million Hearts Initiative Strategic Framework.This afternoon you will hear highlights from the American Heart Association's recent sodium conference from Emily Ann Miller, National Program Lead, Sodium Reduction Initiative with the American Heart Association.You will then learn about and discuss the Institute of Medicine's 2013 report "Sodium Intake in Populations: Assessment of Evidence” fromDr. Cheryl A. M. Anderson, Associate Professor in the Department of Family and Preventive Medicine with the University of California San Diego School of Medicine.You will then hear about the future direction of procurement policies from Dr. Laurie Whitsel, Director of Policy Research with the American Heart AssociationThe final presentation is from John Clymer, Executive Director of the National Forum for Heart Disease and Stroke Prevention who will discuss ways to support and engage in Million Hearts activities.Lastly, there will be a question and answer session at the end of all the presentations. You will submit questions online. This is private and not viewable by other participants. Please direct your questions to All Panelists and then hit the submit button.I will now turn the program over to Emily to begin.
4 AHA Sodium Conference Highlights Emily Ann Miller, MPH, RD National Program Lead, Sodium Reduction Initiative American Heart Association
5 Date: June 19-20, 2013; Arlington, VA Attendees: 140 stakeholders from various sectorsPurpose:Create an interactive and collaborative environment to discuss the status and future implications of reducing sodium in the food supply and to identify opportunities for stakeholder collaboration.Not intended to debate the appropriate level of sodium intake, i.e. 2,300mg vs. 1,500mg, rather, to coalesce around our common groundJune 19-20, 2013; Arlington, VA. The conference was being planned for at least a year before its date.Invitation-only, due to venue space limitations and desire to promote an intimate environment, where everyone is a participant; media not invited140 stakeholders engaged in research and development; food ingredients, manufacturing, and retail; foodservice; regulatory and legislative activities; public health initiatives; and monitoring and surveillancePurpose: create an interactive and collaborative environment to discuss the status and future implications of reducing sodium in the food supply. We wanted an opportunity for dialogue and discussion, where people could learn from each others’ successes and challenges and identify opportunities for collaboration. It was valuable to have stakeholders from various sectors at the table so we could share current data and updates, understand each other’s perspectives and challenges, and identify ways to work together to overcome the challenges.Not intended to debate the appropriate level of sodium intake, i.e. 2,300mg vs. 1,500mg, rather, to coalesce around our common ground which is that Americans’ current intakes of 3,400mg/day are higher than any public health recommendation and need to be reduced.
6 Planning CommitteeElliott Antman, MD, Brigham and Women’s Hospital and Harvard Medical School – AHA President-ElectLarry Appel, MD, MPH, Johns Hopkins University – Chair, Sodium Reduction Advisory Task ForceDoug Balentine, PhD, Unilever – Chair, Industry Nutrition Advisory PanelRachel Johnson, PhD, MPH, RD, University of Vermont – Chair, Nutrition CommitteeLyn Steffen, PhD, MPH, RD, University of Minnesota – EPI Council Liaison to Nutrition CommitteeAHA staff worked with a planning committee to develop the conference agenda and select speakers. The planning committee included experts from academia, healthcare, public health, and industry. All of them hold leadership roles on AHA volunteer committees.
7 ObjectivesAssess the current status and future implications of efforts to reduce sodium in the food supply.Leverage expertise from different disciplines to identify and evaluate sodium reduction strategies; address opportunities and challenges.Discuss ways to translate sodium reduction strategies into practical application.Identify short-term and long-term goals sodium reduction goals and factors that impact timelines for achieving these goals.Identify collaboration opportunities among stakeholders.Identify metrics and methodologies for evaluating the collective impact of sodium reduction efforts on the food supply and on health outcomes.We hope that this conference will help attendees learn more about sodium reduction strategies that have been tried or may be options for future implementation, and how they can translate those strategies into practical application.We also want to identify short- and long-term goals for sodium reduction, and get an idea of the timelines for both types of goals.We also need to know what data we need to collect that will tell us whether we’ve been successful.
8 Agenda Plenary Sessions Science behind sodium reduction and public health recommendationsMeasurement of sodium intakesConsumer knowledge, attitudes, and behaviors re: sodiumFood technology and solutions for sodium reductionFood industry experiences and perspectivesPotential policy and education strategies for sodium reductionBreakout sessionsAgenda included plenary sessions with presentations by topic experts, panel discussions, and breakout sessions. The presentations focused on topics on this slide, such as…The plenary sessions were held on Day 1 and the morning of Day 2; the rest of the time on Day 2 was devoted to breakout sessions.
9 Breakout SessionsOpportunity for participants to contribute their expertise and thoughtsIntended to identify areas that are ripe for further investigation and possibly, future action4 facilitator-led breakout groupsMajor takeaways from presentations; key determinants of success; guiding principles for future actions; most promising solutions and how to overcome their potential barriers; roles for various sectorsThe breakout sessions were an opportunity for each participant to contribute his or her expertise and thoughts. The purpose of these groups was not to emerge with iron-clad recommendations about strategies to reduce sodium intake, but instead to identify areas that are ripe for further investigation and potential future action.We had 4 groups, each led by a facilitator, and all 4 facilitators led their groups through the same breakout discussion guide.Groups discussed several topics, starting with the major takeaways from the plenary sessions.Determinants of success – what elements must be present in strategies to reduce sodium intakes and sodium in the food supply?Examples: multi-sector collaboration; win-win for industry and consumers; realistic solutionsGuiding principles for evaluating and recommending alternative actions and/or decisions to reduce sodiumExamples: evidence-based; measurability (both short and long term); transparencyRoles for the various sectors – academia, health professionals, public health, government, industry, retailers, chefs/culinary
10 Themes from Breakout Sessions ComplexityCommitmentCollaborationCommunicationConsistencyCommon GroundSeveral themes emerged from the breakout discussions, all of which happen to begin with the letter C.
11 Themes from Breakout Sessions ComplexitySodium reduction involves much more than just taking out the saltCommitmentIt will be a long term effort; some progress has been made but there is much more work ahead; lowering sodium in the food supply is criticalCollaborationIt is imperative to have simultaneous, multi-sector effortsCommunication/ConsistencyWe need simple, positive, consistent messages that are culturally-appropriate and come from multiple voicesCommon GroundIncorporate sodium as part of a total health/total diet approach and reap multiple benefits for cardiovascular healthComplexity: Sodium reduction is here to stay and will be a long-term effort because it is complex and challenging, (and there are unique challenges of packaged goods vs. restaurants/foodservice), more complicated than just adjusting flavor, and we must be careful to avoid unintended consequencesCommitment: There is optimism about the progress that has been made but there’s still a lot more work ahead (want to see a drop in consumer sodium intakes)Commitment: Lowering sodium in the food supply is criticalKey question: Do we pursue technologies that decrease sodium but still make food taste the same, or do we actually lower salt taste preferences?Stealth reductions are effective and should continueWe need more sodium-lowering technologies – opportunity to innovateLevel playing field is neededCollaboration: It is imperative to have simultaneous, multi-sector effortsCommunication/Consistency: To motivate consumer behavior change and education, there is a need for clear, simple, consistent, positive, messages that are culturally-appropriate/relevant and come from multiple voices (AHA, gov’t, industry, others)Common ground: We should incorporate sodium as part of a “total health/total diet” approach where healthy is the default; there is also synergy in this kind of approach – reducing kcals through increasing K+-rich fruits/veg should achieve not only population-wide Na reduction but other health benefits as wellOthers:--The current focus of the political environment (FDA) is on promoting voluntary approaches to sodium reduction, not mandatory approaches, and procurement policies were mentioned several times has having a lot of promise--There is value in the collecting and sharing data to direct and re-direct our efforts, need more systematic and transparent ways of sharing data
12 Conference Proceedings Proceedings to be published in an AHA journalEstimated timing: January 2014THANK YOU!Emily Ann Miller, MPH, RDComplexity: Sodium reduction is here to stay and will be a long-term effort because it is complex and challenging, (and there are unique challenges of packaged goods vs. restaurants/foodservice), more complicated than just adjusting flavor, and we must be careful to avoid unintended consequencesCommitment: There is optimism about the progress that has been made but there’s still a lot more work ahead (want to see a drop in consumer sodium intakes)Commitment: Lowering sodium in the food supply is criticalKey question: Do we pursue technologies that decrease sodium but still make food taste the same, or do we actually lower salt taste preferences?Stealth reductions are effective and should continueWe need more sodium-lowering technologies – opportunity to innovateLevel playing field is neededCollaboration: It is imperative to have simultaneous, multi-sector effortsCommunication/Consistency: To motivate consumer behavior change and education, there is a need for clear, simple, consistent, positive, messages that are culturally-appropriate/relevant and come from multiple voices (AHA, gov’t, industry, others)Common ground: We should incorporate sodium as part of a “total health/total diet” approach where healthy is the default; there is also synergy in this kind of approach – reducing kcals through increasing K+-rich fruits/veg should achieve not only population-wide Na reduction but other health benefits as wellOthers:--The current focus of the political environment (FDA) is on promoting voluntary approaches to sodium reduction, not mandatory approaches--There is value in the collecting and sharing data to direct and re-direct our efforts, need more systematic and transparent ways of sharing data
13 Sodium Intake in Populations: Assessment of Evidence, 2013 IOM Report Cheryl Anderson, PhD, MPH, MS Associate Professor, Department of Familyand Preventive Medicine University of California San Diego School of Medicine
14 Sodium Intake in Populations: Assessment of Evidence
15 Statement of TaskEvaluate the results, study design, and methodological approaches to assessing the relationship between sodium and health outcomes in the literature since 2003.Evaluate potential benefits/adverse impacts of reduced population sodium intake (i.e. 1,500 – 2,300 mg/day) in the population generally and for population subgroups (those with hypertension and prehypertension, those 51 years of age and older, African Americans, and those with diabetes, chronic kidney disease, and congestive heart failure).Comment on the implications for population-based strategies to reduce sodium intake.Identify data and methods gaps and suggest ways to address them.
17 Step 2: Review and Evaluation of Studies Criteria:Generalizability to the populations of interestGeneral U.S. populationSubgroups (hypertensive/prehypertensive, 51 years and older, African American, those with diabetes, chronic kidney disease, and congestive heart failure)Methodological appropriatenessStudy designQuantitative measures of dietary sodium intakeConfounder adjustmentNumber and consistency of relevant studies available
18 Factors that Impacted Evaluation Variability in the types and quality of measures used in observational studies and clinical trialsLack of consistency among studies in the methods used for defining sodium intakes at both high and low ends of the range of typical intakesExtreme variability in intake levels between and among population groupsprecluded the committee from establishing a “healthy” intake range.Committee could consider sodium intake levels only within the context of each individual study.
19 Overarching Findings Many populations evaluated were outside the US included groups that consumed mean levels of sodium much higher than the average amount consumed by adults in the USThe quantity and quality of relevant studies was less than optimallimitations associated with the quantitative measures of sodium intakepotential for spurious findings related to incorrect measurement and reverse causalityVariability in the types and quality of measures used, so that measures could not be reliably calibrated across studies
20 Findings and Conclusions General Population Finding 1: Results from studies linking dietary sodium intake with direct health outcomes were highly variable in methodological quality, particularly in assessing sodium intake. The range of limitations included over- or under-reporting of intakes or incomplete collection of urine samples. In addition, variability in data collection methodologies limited the committee’s ability to compare results across studies. Conclusion 1: Given the methodological flaws and limitations, when considered collectively, the evidence indicates a positive relationship between higher levels of sodium intake and risk of CVD. This evidence is consistent with existing evidence on blood pressure as a surrogate indicator of CVD risk.
21 General PopulationFinding 2: Evidence from studies on direct health outcomes was insufficient and inconsistent regarding an association between sodium intake below 2,300 mg per day and benefit or risk of CVD outcomes (including stroke and CVD mortality) or all-cause mortality in the general US population. Conclusion 2: Evidence from studies on direct health outcomes is inconsistent and insufficient to conclude that lowering sodium intakes below 2,300 mg/day either increases or decreases risk of CVD outcomes (including stroke and CVD mortality) or all-cause mortality in the general U.S. population.
22 Population SubgroupsFinding 1: Evidence from multiple randomized controlled trials (RCTs) that were conducted by a single investigative team indicated that low sodium intake (e.g., to 1,840 mg/day) may lead to greater risk of adverse events in congestive heart failure (CHF) patients with reduced ejection fraction and who are receiving certain aggressive therapeutic regimens. This association also is supported by one observational study where low sodium intake levels in patients with CVD and diabetes were associated with higher risk of CHF events. Conclusion 1: Evidence suggests that low sodium intakes may lead to higher risk of adverse events in mid- to late-stage CHF patients with reduced ejection fraction and who are receiving aggressive therapeutic regimens. Because these therapeutic regimens were very different than current standards of care in the US, the results may not be generalizable. Similar studies in other settings and using regimens more closely resembling those in standard U.S. clinical practice are still needed.
23 Population SubgroupsFinding 2: Data among prehypertensive participants from two related studies provided some evidence suggesting a continued benefit of lowering sodium intake in these patients down to 2,300 mg per day (and lower, although based on small numbers in the lower range). No evidence was found for benefit and some evidence suggesting risk of adverse health outcomes associated with sodium intake levels in ranges approximating 1,500 to 2,300 mg per day in other disease-specific population subgroups (those with diabetes, chronic kidney disease (CKD), or pre-existing CVD).
24 Population SubgroupsFinding 2: In addition to inconsistencies in sodium intake measures, methodological flaws included the possibility of confounding and reverse causality. No relevant evidence was found on health outcomes for other population subgroups considered (i.e., persons 51 years of age and older, and African Americans). In studies that explored interactions, race, age, or the presence of hypertension or diabetes did not change the effect of sodium on health outcomes.
25 Population SubgroupsConclusion 2: With the exception of CHF patients, the current body of evidence addressing the association between low sodium intake and health outcomes in the population subgroups considered is limited. The evidence available is inconsistent and limited in its approaches to measuring sodium intake. The evidence also is limited by small numbers of health outcomes and the methodological constraints of observational study designs, including the potential for reverse causality and confounding.
26 Population SubgroupsConclusion 2: While the current literature provides some evidence for adverse health effects of low sodium intake among individuals with diabetes, CKD, or pre-existing CVD, the evidence on both the benefit and harm is not strong enough to indicate that these subgroups should be treated differently from the general U.S. population. Thus, the evidence on direct health outcomes does not support prior recommendations to lower sodium intake within these subgroups to, or even below, 1,500 mg/day.
27 Implications for Population-based Strategies The available evidence on associations between sodium intake and direct health outcomes is consistent with population-based efforts to lower excessive dietary sodium intakes, but it is not consistent with efforts that encourage lowering of dietary sodium in the general population to 1,500 mg/day.The evidence reviewed also suggests that dietary sodium intake may affect heart disease risk through pathways in addition to blood pressure.
28 Implications for Population-based Strategies Further research may shed more light on the association between lower (1,500 to 2,300 mg) levels of sodium and health outcomes in the general population and subpopulations. The committee was not asked to draw conclusions about a specific target range of dietary sodium. Other factors also precluded specifying a such range. These included methodologic problems in assessing sodium intake and difficulty calibrating those measures across different approaches to measuring intake and different study designs.
29 CommitteeBRIAN L. STROM (Chair), University of Pennsylvania CHERYL A.M. ANDERSON, University of California San Diego JAMY ARD, Wake Forest Baptist Health KIRSTEN BIBBINS-DOMINGO, University of California San Francisco NANCY R. COOK, Brigham & Women’s Hospital MARY KAY FOX, Mathematica Policy Research NIELS GRAUDAL, Copenhagen University Hospital JIANG HE, Tulane University JOACHIM IX, Veterans Affairs San Diego Healthcare System STEPHEN E. KIMMEL, University of Pennsylvania ALICE H. LICHTENSTEIN, Tufts University MYRON WEINBERGER, Indiana University
30 Future Direction of Procurement Policy Laurie Whitsel, PhD Director of Policy Research American Heart Association
31 The AHA’s 2010-2014 Strategic Policy Agenda Focuses on Achieving our 2020 Goals Decrease deaths from CVD and StrokeImprove the overall CV health of AmericansThe current agenda focuses on areas that will reach the 2020 goal of decreasing death from CVD and stroke, and improve the overall cardiovascular health of Americans.
32 ProcurementIncreasing attention on the importance of creating healthier work environments and healthier food options to the public in different settings.
33 Procurement Potential Environments government buildings hospital systemscollege/university campusesSchools/child care centersassisted living facilitiesfaith-based organizationsprivate corporationstheme parks/resortsprisonsnon-profit organizations
34 ProcurementTargets for nutrition standards for food and beverage procurementVending machinesCafeteriasConcession standsMeetings/conferencesOrganizational events
35 Procurement Numerous existing model standards AHA HHS/Federal GovernmentMunicipal governmentsNational Alliance for Nutrition and ActivityAlliance for a Healthier Generation
36 Forthcoming AHA Paper Will address such issues as: Existing model standardsBarriers to implementationLegal issuesCase studiesImportance of Evaluation
37 The Future of Procurement Policy Where do we go from here?
38 Procurement A relatively new area of policy development Will require an assessment of the impact of the numerous existing policies across the U.S.Consistent evaluation forPurchasing behaviorAvailability of healthy food in purchasingAffordability/Cost IssuesHealth impactLevels of adoptionIndustry response
39 Million Hearts® Support and Engagement John Clymer Executive Director National Forum for Heart Disease and Stroke Prevention
40 The Million Hearts® Initiative Goal: Prevent 1 million heart attacksand strokes in 5 yearsNational initiative co-led by CDC and CMSPartners across federal, state, and local government and private organizationsMillion Hearts® is a national initiative to prevent 1 million heart attacks and strokes in the U.S. by Launched by the U.S. Department of Health and Human Services (HHS) in September 2011, it aligns existing efforts, as well as creates new programs, to improve health across communities and help Americans live longer, more productive lives. The Centers for Disease Control and Prevention (CDC) and Centers for Medicare & Medicaid Services (CMS), co-leaders of Million Hearts® within HHS, are working alongside federal, state, and local entities and private-sector organizations to make a long-lasting impact against cardiovascular disease.
41 CDC Million Hearts® Collaboration American Heart AssociationNational Forum for Heart Disease & Stroke PreventionAssociation of State and Territorial Health OfficialsNational Association of City County Health OfficialsNational Association of Chronic Disease DirectorsThe American Heart Association and the National Forum for Heart Disease and Stroke Prevention are co-leading the CDC Million Hearts Collaboration, which includes the Association of State and Territorial Health Officials, the National Association of Chronic Disease Directors with its Cardiovascular Health Council, and the National Association of County and City Health Officials. The goals of the Collaboration are to coordinate and disseminate priority messages and strategies related to Million Hearts, as well as encourage new stakeholder engagement.
42 Key ComponentsImprove care for people who need treatment by encouraging a targeted focus on the “ABCS”Empower Americans to make healthy choices such as not using tobacco and reducing sodium and trans fat consumptionMillion Hearts® is seeking participation from organizations interested in targeting improvements in clinical preventive practice and/or community prevention. You can do this by implementing programs, projects or initiatives for the following:Improve care for people who do need treatment by encouraging a targeted focus on the “ABCS”—Aspirin for people at risk, Blood pressure control, Cholesterol management, and Smoking cessation—which address the major risk factors for cardiovascular disease and can help to prevent heart attacks and strokes.Empower Americans to make healthy choices such as preventing tobacco use and reducing sodium and trans fat consumption. This can help reduce the number of people who need medical treatment such as blood pressure or cholesterol medications to prevent heart attacks and strokes.
43 Actions You Can TakeAlign existing initiatives and programs with Million Hearts® goalsConvene partners, stakeholders, and policy makers for Million Hearts® for planning purposesShare success stories on Million Hearts®Actions organizations can take to advance Million Hearts® include the following:Align existing initiatives and programs with Million Hearts® goals, for example, using patient and provider reminder systems and matching your policy agenda to Million Hearts goals.Convene partners, stakeholders, and policy makers for Million Hearts® for planning purposes (in a few minutes I will share a new resource created by the Collaboration on State Engagement and working with key partners).And Share success stories on Million Hearts® through Community Commons, through your own organization newsletters and other communications channels.
44 Ways to Use Million Hearts® to Achieve Your 0rganizations goals Join Community Commons – Connect, Share, and Collaborate on Million Hearts® ActivitiesBecome a Million Hearts® PartnerPledge Support on the Million® Hearts Website – Be One in a Million Hearts®Ways to Use Million Hearts® to Achieve Your 0rganizations goalsCommunity CommonsMany organizations at all levels are hearing about Million Hearts® and are committing to various Million Hearts® Goals. Helping these organizations find each other is a main function of Community Commons (http://www.communitycommons.org/). Community Commons is a web-based interactive mapping, networking, and learning utility where you can highlight your organization’s Million Hearts® activities; share ideas and best practices; and collaborate with other organizations in your community. Individuals can register and join the Million Hearts® Group profile. They can also work with their organizations to create an Initiative Profile so that their organization is recognized as part of the Million Hearts® cohort on the Map of the Movement. We encourage you to post your Million Hearts® activities, questions, and comments on Community Commons.PartnersMillion Hearts® Partners are organizations that make a formal commitment to the initiative. This formal commitment includes concise and specific action steps that the organization proposes to conduct in support of the Million Hearts® initiative, with explicit timelines for completion, measurable results, and rationale for how it will help support the goal. Partners from across the public and private health sectors are supporting Million Hearts® through a wide range of activities.Organizations interested in becoming Million Hearts® Partners are asked to review their mission and portfolio, and identify specific steps they will take to support the Million Hearts® goal.States are encouraged to become official Million Hearts® partners, but it is not required. Many states are doing great work in support of Million Hearts® and may not be listed on the website for various reasons.Pledging SupportPledging your support for Million Hearts® means you are promising to help achieve a greater impact on cardiovascular health throughout the United States. Any individual or organization can pledge by visiting the Be One in a Million Hearts® tab on the Million Hearts® website, specifying individual or choosing the appropriate organization type, and filling in the fields and clicking ‘Count Me In'. Through this process you will be added to the overall number of Million Hearts® Pledges. CDC will not contact you for information about your activities. However, this information provides the Million Hearts® Team with the location of your efforts and is showcased on a map of individuals and organizations who pledged under the Be One in a Million Hearts® tab.
45 State Engagement Guide Includes information on the initiativeWays to use Million Hearts® to achieve your organization’s goalsLessons learned and key recommendations, Workshop descriptionsExamples, resources, and information on how the Collaboration organizations can assist in working with Million Hearts®I wanted to also share with you a new resource developed by the CDC Million Hearts® Collaboration. The Collaboration created a State Engagement Guide to support states in their Million Hearts efforts. The Guide includes information on the initiative as well as ways to support Million Hearts®, lessons learned and key recommendations, workshop descriptions and examples, resources, and information on how the Collaboration organizations can assist in working with Million Hearts®. While states were the intended audience for this guide, there is useful information for organizations to reference with Million Hearts® engagement.(This is the last slide – transition to Jill for Q and A)
46 National Forum Members / Million Hearts® Partners American College of CardiologyNational Association of County and City Health OfficialsAmerican Heart AssociationNational Heart, Lung, and Blood InstituteAmerican Medical Group FoundationNational Lipid AssociationAssociation of Black Cardiologists, Inc.Preventive Cardiovascular Nurses AssociationAssociation of State and Territorial Health OfficialsU.S. Department of Health and Human ServicesCenters for Disease Control and PreventionU.S. Department of Veterans Affairs, Ischemic Heart Disease Quality Enhancement Research InitiativeHealth Resources and Services AdministrationIndian Health ServiceU.S. Food and Drug Administration, Office of Women's HealthNational Association of Chronic Disease DirectorsWomenHeartYMCA19 National Forum member organizations are also Million Hearts partners
47 Questions & AnswersIt is now time for the question and answer session. Please submit questions online. This is private and not viewable by other participants. Please direct your questions to All Panelists and then hit the submit button. I will then read the questions and seek a panelists for response.Jill Birnbaum, JD Vice President, State Advocacy & Public Health American Heart Association
48 AHA ActivitiesI wanted to also share with you a new resource developed by the CDC Million Hearts® Collaboration. The Collaboration created a State Engagement Guide to support states in their Million Hearts efforts. The Guide includes information on the initiative as well as ways to support Million Hearts®, lessons learned and key recommendations, workshop descriptions and examples, resources, and information on how the Collaboration organizations can assist in working with Million Hearts®. While states were the intended audience for this guide, there is useful information for organizations to reference with Million Hearts® engagement.(This is the last slide – transition to Jill for Q and A)
49 Thank You! For more information, please visit millionhearts.hhs.gov Thank you for attending the Webinar today. You will receive a short survey as you exit.